These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9630583)

  • 1. Norepinephrine efflux evoked by potassium chloride in cat sympathetic nerves: dual mechanism of action.
    Yamazaki T; Akiyama T; Kawada T; Kitagawa H; Takauchi Y; Yahagi N; Sunagawa K
    Brain Res; 1998 May; 794(1):146-50. PubMed ID: 9630583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. omega-Conotoxin GVIA and desipramine insensitive norepinephrine efflux from cardiac sympathetic nerve terminal.
    Yamazaki T; Kawada T; Akiyama T; Kitagawa H; Takauchi Y; Yahagi N; Sunagawa K
    Brain Res; 1997 Jul; 761(2):329-32. PubMed ID: 9252033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ouabain on in situ cardiac sympathetic nerve endings.
    Yamazaki T; Akiyama T; Kawada T
    Neurochem Int; 1999 Dec; 35(6):439-45. PubMed ID: 10524711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of omega-conotoxin GVIA on cardiac sympathetic nerve function.
    Yahagi N; Akiyama T; Yamazaki T
    J Auton Nerv Syst; 1998 Jan; 68(1-2):43-8. PubMed ID: 9531444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dialysate dihydroxyphenylglycol as a window for in situ axoplasmic norepinephrine disposition.
    Yamazaki T; Akiyama T; Kitagwa H; Kawada T; Sunagawa K
    Neurochem Int; 2001 Mar; 38(3):287-92. PubMed ID: 11099788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new, concise dialysis approach to assessment of cardiac sympathetic nerve terminal abnormalities.
    Yamazaki T; Akiyama T; Kitagawa H; Takauchi Y; Kawada T; Sunagawa K
    Am J Physiol; 1997 Mar; 272(3 Pt 2):H1182-7. PubMed ID: 9087591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NG-nitro-L-arginine methyl ester-induced norepinephrine release from cardiac sympathetic nerve endings in anesthetized cats.
    Takauchi Y; Yamazaki T; Akiyama T; Sunagawa K
    Neurosci Lett; 2003 Dec; 353(3):205-8. PubMed ID: 14665417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of ouabain-induced noradrenaline and acetylcholine release from in situ cardiac autonomic nerve endings.
    Yamazaki T; Akiyama T; Kitagawa H; Komaki F; Mori H; Kawada T; Sunagawa K; Sugimachi M
    Acta Physiol (Oxf); 2007 Dec; 191(4):275-84. PubMed ID: 17995575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ketamine on in vivo cardiac sympathetic nerve endings.
    Kitagawa H; Yamazaki T; Akiyama T; Mori H; Sunagawa K
    J Cardiovasc Pharmacol; 2001 Oct; 38 Suppl 1():S39-42. PubMed ID: 11811357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sustained limb ischemia on norepinephrine release from skeletal muscle sympathetic nerve endings.
    Kuroko Y; Tokunaga N; Yamazaki T; Akiyama T; Ishino K; Sano S; Mori H
    Neurochem Int; 2006 Oct; 49(5):448-53. PubMed ID: 16632086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulatory effects of ketamine on catecholamine efflux from in vivo cardiac sympathetic nerve endings in cats.
    Kitagawa H; Yamazaki T; Akiyama T; Yahagi N; Kawada T; Mori H; Sunagawa K
    Neurosci Lett; 2002 May; 324(3):232-6. PubMed ID: 12009530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyramine-induced endogenous noradrenaline efflux from in situ cardiac sympathetic nerve ending in cats.
    Takauchi Y; Yamazaki T; Akiyama T
    Acta Physiol Scand; 2000 Feb; 168(2):287-93. PubMed ID: 10712566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ketamine on exocytotic and non-exocytotic noradrenaline release.
    Kitagawa H; Yamazaki T; Akiyama T; Mori H; Sunagawa K
    Neurochem Int; 2003 Feb; 42(3):261-7. PubMed ID: 12427480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyanide intoxication induced exocytotic epinephrine release in rabbit myocardium.
    Kawada T; Yamazaki T; Akiyama T; Sato T; Shishido T; Inagaki M; Tatewaki T; Yanagiya Y; Sugimachi M; Sunagawa K
    J Auton Nerv Syst; 2000 May; 80(3):137-41. PubMed ID: 10785279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Either desipramine or TMB-8 suppresses cyanide-induced norepinephrine efflux from in vivo cardiac sympathetic nerves of cats.
    Yahagi N; Yamazaki T; Akiyama T
    Brain Res; 2000 May; 864(1):157-61. PubMed ID: 10793201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo monitoring of norepinephrine and its metabolites in skeletal muscle.
    Tokunaga N; Yamazaki T; Akiyama T; Sano S; Mori H
    Neurochem Int; 2003 Nov; 43(6):573-80. PubMed ID: 12820986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial interstitial noradrenaline monitoring during occlusion of inferior vena cava in cats.
    Kitagawa H; Akiyama T; Yamazaki T
    Acta Physiol Scand; 1998 Jun; 163(2):173-9. PubMed ID: 9648636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevation of either axoplasmic norepinephrine or sodium level induced release of norepinephrine from cardiac sympathetic nerve terminals.
    Yamazaki T; Akiyama T; Kitagawa H; Takauchi Y; Kawada T
    Brain Res; 1996 Oct; 737(1-2):343-6. PubMed ID: 8930389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial interstitial norepinephrine and dihydroxyphenylglycol levels during ischemia and reperfusion.
    Akiyama T; Yamazaki T
    Cardiovasc Res; 2001 Jan; 49(1):78-85. PubMed ID: 11121798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of locally administered desipramine on myocardial interstitial norepinephrine levels.
    Yamazaki T; Akiyama T
    J Auton Nerv Syst; 1996 Dec; 61(3):264-8. PubMed ID: 8988484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.